Natera Inc logo

Natera Inc

1
NAS:NTRA (USA)  
$ 162.39 +0.4 (+0.25%) 01:00 PM EST
At Loss
P/B:
22.88
Market Cap:
$ 21.39B
Enterprise V:
$ 20.96B
Volume:
286.60K
Avg Vol (2M):
1.34M
Trade In:
Volume:
286.60K
At Loss
Avg Vol (2M):
1.34M

Business Description

Description
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
Name Current Vs Industry Vs History
Cash-To-Debt 1.94
Equity-to-Asset 0.55
Debt-to-Equity 0.54
Debt-to-EBITDA -2.8
Piotroski F-Score 7/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 17.14
Distress
Grey
Safe
Beneish M-Score -2.53
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 45.07
9-Day RSI 47.66
14-Day RSI 52.13
6-1 Month Momentum % 56.16
12-1 Month Momentum % 174.92

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.39
Quick Ratio 4.23
Cash Ratio 3.06
Days Inventory 24.26
Days Sales Outstanding 69.81
Days Payable 13.88

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -11.5
Shareholder Yield % -0.02

Financials (Next Earnings Date:2025-02-28 Est.)

NTRA's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:NTRA

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Natera Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 1,531.955
EPS (TTM) ($) -1.76
Beta 1.75
Volatility % 46.37
14-Day RSI 52.13
14-Day ATR ($) 6.695989
20-Day SMA ($) 166.6705
12-1 Month Momentum % 174.92
52-Week Range ($) 58.53 - 175.63
Shares Outstanding (Mil) 132.02

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 7
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Natera Inc Filings

Filing Date Document Date Form
No Filing Data

Natera Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Natera Inc Frequently Asked Questions

What is Natera Inc(NTRA)'s stock price today?
The current price of NTRA is $162.39. The 52 week high of NTRA is $175.63 and 52 week low is $58.53.
When is next earnings date of Natera Inc(NTRA)?
The next earnings date of Natera Inc(NTRA) is 2025-02-28 Est..
Does Natera Inc(NTRA) pay dividends? If so, how much?
Natera Inc(NTRA) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1